A tyrosine kinase inhibitor (TKI) or tyrosine phosphorylation inhibitor (Tyrphostin) is a pharmaceutical drug that inhibits RTK. (https://en.wikipedia.org/wiki/Tyrosine-kinase_inhibitor)
RTK를 인산화시키는 과정을 저해한다.
주요 약물
- Nilotinib for BCR/ABL1 Fusion gene
- Imatinib for CML
- Gefitinib, Erlotinib at EGF receptor
- Sunitinib at FGF, PDGF, VEGF
Table of Contents
Incoming Links #
Related Medical Scholarly Articles (MedicalScholarlyArticle 0) #
Related Articles (Article 1) #
Related Drugs (Drug 2) #
Suggested Pages #
- 0.150 Biomarkers in triple negative breast cancer: A review
- 0.103 The cancer genome
- 0.025 Oncogene
- 0.025 Cell division
- 0.025 BCF
- 0.025 Vascular endothelial growth factor
- 0.025 November 1
- 0.025 Cytokine
- 0.025 Vascular permeability factor
- 0.025 VPF
- More suggestions...